Patent Assignment
Reel/Frame 004835/0641
Assignment of Assignors Interest.
Recorded: 1988-03-07
Pages: 2
Assignor
ARMOUR PHARMACEUTICAL COMPANY
Executed: 1988-03-03
Assignee
RORER PHARMACEUTICAL CORPORATION, A CORP. OF DE.
500 VIRGINIA DRIVE, FORT WASHINGTON, PENNSYLVANIA, 19034
Covered Properties
(7)
Des-19-Leucine, 20-Glutamine-Calcitonin
Patent:
4,732,969 →
Application:
06/859,527 →
8-Glycine, Des-19-Leucine-Calcitonin
Patent:
4,746,728 →
Application:
06/859,569 →
Amide Analogs of Calcitonin
Patent:
4,804,742 →
Application:
06/938,671 →
Des-19-Leucine, 20-Glutamine, 21-Threonine-Calcitonin
Patent:
4,764,590 →
Application:
07/040,963 →
Analogs of (1,7-Di-Alanine, Des-19-Leucine)
Patent:
4,820,804 →
Application:
07/040,964 →
Des-19-Leucine, 20-Glutamine, 21-Threonine, 22-Tyrosine-Calcitonin
Patent:
4,764,591 →
Application:
07/040,966 →
(19-Alanine) Calcitonin
Patent:
4,824,936 →
Application:
07/047,798 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
May 5, 1986
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 004550/0753 →
Assignment of Assignors Interest.
May 5, 1986
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.; GEEVER, JAMES E.
To: ARMOUR PHARMACEUTICAL CORPORATION
Reel/Frame 004550/0766 →
Assignment of Assignors Interest.
May 6, 1987
From: ORLOWSKI, RONALD C.; STAHL, GLENN L.; COLESCOTT, ROBERT L.
To: RORER PHARMACEUTICAL CORPORATION, A CORP OF DE.
Reel/Frame 004713/0307 →
Merger Effective Date: December 30, 1986
Jun 9, 1987
From: WILLIAM H. RORER, INC. (MERGED INTO); USV PHARMACEUTICAL CORPORATION (CHANGED TO)
To: RORER PHARMACEUTICAL CORPORATION, A CORP. OF DE.
Reel/Frame 004725/0703 →
Assignment of Assignors Interest.
Aug 21, 1987
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.; FLANIGAN, EVERETT
To: RORER PHARMACEUTICAL CORPORATION
Reel/Frame 004832/0977 →
Assignment of Assignors Interest.
Apr 21, 1988
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: RORER PHARMACEUTICAL CORPORATION
Reel/Frame 004832/0957 →
Change of Name Effective on 09/10/1990
Nov 9, 1990
From: RORER PHARMACEUTICALS INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 005563/0007 →